Quarterly report pursuant to Section 13 or 15(d)

Significant Accounting Policies - Additional Information (Details)

v3.22.2
Significant Accounting Policies - Additional Information (Details) - USD ($)
$ in Millions
 1 Months Ended 6 Months Ended 12 Months Ended
Jan. 01, 2022
Jan. 31, 2022
Jun. 30, 2022
Dec. 31, 2021
Mar. 17, 2015
Percentage of annual equity fee         2.50%
Fortress Biotech, Inc          
Percentage of annual equity fee 2.50%   2.50%    
Number of common stock shares issued 2,121,422 2,121,422 107,632    
Research and development          
Value of common stock shares issued       $ 6.6